🇨🇦 Dupilumab - Discontinuation in Canada

Dupilumab - Discontinuation (Dupilumab - Discontinuation) regulatory status in Canada.

Marketing authorisation

Dupilumab - Discontinuation in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dupilumab - Discontinuation approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Dupilumab - Discontinuation in Canada?

Johns Hopkins University is the originator. The local marketing authorisation holder may differ — check the official source linked above.